SCHEMBL9280668

SCHEMBL9280668

Cc1[nH]c2ccccc2c1-c1ccc[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.51
AHR P35869 1/20 0.50
ALDH1A1 P00352 5/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 3/20 0.49
HSD17B10 Q99714 3/20 0.49
LMNA P02545 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CCR6 P51684 1/20 0.46
HKDC1 Q2TB90 1/20 0.46
HTT P42858 3/20 0.45
GAA P10253 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
RAD52 P43351 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6628898 0.75 IMPDH2 (0.55) IMPDH2AHRALDH1A1MAPTKDM4E
SCHEMBL29259140 0.73 KIF11 (0.45) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL17383846 0.73 IMPDH2 (0.73) IMPDH2AHRALDH1A1MAPTKDM4E
SCHEMBL6753454 0.72 MEN1 (0.41) AHRALDH1A1MAPTKDM4EHPGD
SCHEMBL18392175 0.72 CCR6 (0.58) IMPDH2AHRALDH1A1MAPTKDM4E
SCHEMBL30277945 0.71 LMNA (0.53) IMPDH2AHRALDH1A1MAPTKDM4E
SCHEMBL16169793 0.70 IMPDH2 (0.69) IMPDH2AHRALDH1A1MAPTKDM4E
SCHEMBL29678164 0.70 IMPDH2 (0.58) IMPDH2AHRALDH1A1MAPTKDM4E
SCHEMBL2013427 0.69 IMPDH2 (0.62) IMPDH2AHRALDH1A1MAPTKDM4E
SCHEMBL8722153 0.68 IMPDH2 (0.65) IMPDH2AHRALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed